Palumbo Wealth Management’s CorMedix CRMD Stock Holding History

Palumbo Wealth Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-46,598	Closed	-$287K	–	200
2025 Q1	$287K	Buy	46,598 +16,272	+54%	+$168K	0.1%	139
2024 Q4	$246K	Buy	30,326 +17,960	+145%	+$179K	0.09%	139
2024 Q3	$99.9K	Buy	+12,366	New	+$66.9K	0.04%	148

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

Palumbo Wealth Management's CRMD Position: Q2 2025 in Review

Palumbo Wealth Management sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 46,598 shares — an estimated $287K sold.

Palumbo Wealth Management first reported a position in CRMD in Q3 2024 and held it in 3 quarters. The position peaked at $287K in Q1 2025. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

Palumbo Wealth Management reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
Palumbo Wealth Management sold 46,598 CorMedix shares in Q2 2025, an estimated $287K.
Palumbo Wealth Management first reported a position in CorMedix in Q3 2024 and held it in 3 quarters.
Palumbo Wealth Management's CorMedix position peaked at $287K in Q1 2025.
172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Palumbo Wealth Management's 13F filing for Q2 2025, filed 15 Jul 2025.